JPWO2022052964A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022052964A5 JPWO2022052964A5 JP2023515253A JP2023515253A JPWO2022052964A5 JP WO2022052964 A5 JPWO2022052964 A5 JP WO2022052964A5 JP 2023515253 A JP2023515253 A JP 2023515253A JP 2023515253 A JP2023515253 A JP 2023515253A JP WO2022052964 A5 JPWO2022052964 A5 JP WO2022052964A5
- Authority
- JP
- Japan
- Prior art keywords
- expression
- functional
- functional fragments
- promotes
- transcription factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010934192.9A CN114231489A (zh) | 2020-09-08 | 2020-09-08 | 用于重编程的功能性片段、组合及其应用 |
| CN202010934192.9 | 2020-09-08 | ||
| PCT/CN2021/117302 WO2022052964A1 (zh) | 2020-09-08 | 2021-09-08 | 用于重编程的功能性片段、组合及其应用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023540130A JP2023540130A (ja) | 2023-09-21 |
| JPWO2022052964A5 true JPWO2022052964A5 (https=) | 2024-07-30 |
| JP2023540130A5 JP2023540130A5 (https=) | 2024-07-30 |
| JP7680072B2 JP7680072B2 (ja) | 2025-05-20 |
Family
ID=80632100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515253A Active JP7680072B2 (ja) | 2020-09-08 | 2021-09-08 | リプログラミング用機能性断片、組み合わせ、およびその用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240026379A1 (https=) |
| EP (1) | EP4212624A4 (https=) |
| JP (1) | JP7680072B2 (https=) |
| KR (1) | KR20230082024A (https=) |
| CN (2) | CN114231489A (https=) |
| WO (1) | WO2022052964A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117070477A (zh) * | 2022-05-10 | 2023-11-17 | 纽伦捷生物医药科技(上海)有限公司 | 重组溶瘤病毒的重编程的功能性片段、组合及其应用 |
| WO2025108407A2 (en) | 2023-11-23 | 2025-05-30 | Neuexcell Therapeutics (Suzhou) Co., Ltd. | Gene therapy compositions and methods for treating glioma |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010053522A2 (en) * | 2008-10-29 | 2010-05-14 | The Regents Of The University Of California | Methods for identifying and producing neural stem and progenitor cells and their progeny |
| WO2010144696A1 (en) | 2009-06-11 | 2010-12-16 | Burnham Institute For Medical Research | Directed differentiation of stem cells |
| US9057053B2 (en) * | 2010-01-19 | 2015-06-16 | The Board Of Trustees Of The Leland Stanford Junior University | Direct conversion of cells to cells of other lineages |
| EP2531599A4 (en) * | 2010-02-04 | 2014-01-08 | Vivoscript Inc | COMPOSITIONS AND METHODS OF RENEWING CELLS WITHOUT GENETIC MODIFICATION FOR THE TREATMENT OF NEUROLOGICAL SUFFERING |
| WO2014037527A1 (en) * | 2012-09-07 | 2014-03-13 | Cambridge Enterprise Limited | Maturation of mammalian cells by modulation of protein phosphorylation |
| US10076574B2 (en) | 2013-10-25 | 2018-09-18 | Wayne State University | Methods, systems and compositions relating to cell conversion via protein-induced in-vivo cell reprogramming |
| EP3099786A1 (en) * | 2014-01-29 | 2016-12-07 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Trans-differentiation of differentiated cells |
| WO2017081033A1 (en) * | 2015-11-09 | 2017-05-18 | Universite De Nice Sophia Antipolis | Cell differentiation or reprogramming using fezf2 and lmo4 |
| CN107435050B (zh) * | 2017-06-20 | 2021-02-09 | 向孟清 | 一种将人或动物体细胞诱导为神经干细胞的方法 |
| EP3418378B1 (en) * | 2017-06-22 | 2024-12-25 | HI-STEM gGmbH Im Deutschen Krebsforschungszentrum DKFZ | Novel methods for the generation and use of human induced neural border stem cells |
| US20200018746A1 (en) * | 2018-03-14 | 2020-01-16 | The Broad Institute, Inc. | Three-Dimensional Human Neural Tissues for CRISPR-Mediated Perturbation of Disease Genes |
| US20210228741A1 (en) * | 2018-04-27 | 2021-07-29 | University Of Washington | Methods and compositions to stimulate retinal regeneration |
| US20200002679A1 (en) * | 2018-06-05 | 2020-01-02 | Kcellbio Banking Co., Ltd. | Composition for cell regeneration comprising cells hypersecreting growth factors, and at least one of neural stem cells, neurons and gabaergic neurons |
| US20210268126A1 (en) * | 2018-08-23 | 2021-09-02 | Rutgers, The State University Of New Jersey | Treating spinal cord injury (sci) and brain injury using gsx1 |
| CN109385404B (zh) * | 2018-10-19 | 2021-07-06 | 国典(北京)医药科技有限公司 | 一种诱导干细胞分化为神经元的方法及神经元与应用 |
-
2020
- 2020-09-08 CN CN202010934192.9A patent/CN114231489A/zh active Pending
-
2021
- 2021-09-08 JP JP2023515253A patent/JP7680072B2/ja active Active
- 2021-09-08 EP EP21866017.3A patent/EP4212624A4/en active Pending
- 2021-09-08 CN CN202180054720.4A patent/CN116437943A/zh active Pending
- 2021-09-08 WO PCT/CN2021/117302 patent/WO2022052964A1/zh not_active Ceased
- 2021-09-08 US US18/024,504 patent/US20240026379A1/en active Pending
- 2021-09-08 KR KR1020237011913A patent/KR20230082024A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2165969A1 (en) | Vertebrate apoptosis gene: compositions and methods | |
| JP2021520200A5 (https=) | ||
| CN109646668B (zh) | 一种多肽用于制备防治阿尔茨海默病药物的用途 | |
| WO2021031810A1 (zh) | Ptbp1抑制剂在预防和/或治疗功能性神经元死亡相关的神经系统疾病中的应用 | |
| CN112386699A (zh) | Ptbp1抑制剂在预防和/或治疗功能性神经元死亡相关的神经系统疾病中的应用 | |
| JP7680072B2 (ja) | リプログラミング用機能性断片、組み合わせ、およびその用途 | |
| Chen et al. | Identification of Clec7a as the therapeutic target of rTMS in alleviating Parkinson's disease: targeting neuroinflammation | |
| Zhai et al. | Overexpressed ski efficiently promotes neurorestoration, increases neuronal regeneration, and reduces astrogliosis after traumatic brain injury | |
| JP4494863B2 (ja) | Vhlペプチド | |
| JP2021534206A5 (https=) | ||
| JP7828619B2 (ja) | 運動性神経細胞直接交差分化用因子 | |
| WO2021032068A1 (zh) | Ptbp1抑制剂在预防和/或治疗功能性神经元死亡相关的神经系统疾病中的应用 | |
| JP7620338B2 (ja) | 機能性ニューロンへのグリア細胞の分化転換を誘導するためのNeurog2機能性断片送達システム、宿主細胞及び医薬組成物 | |
| US20250115650A1 (en) | Direct transdifferentiation for treatment of neurological disease | |
| JPWO2022052964A5 (https=) | ||
| JP2025515209A (ja) | 組換え腫瘍溶解性ウイルスのリプログラミングさせる機能的断片、組み合わせ及びその応用 | |
| Dias et al. | Perspective on Gene Therapy for Glaucoma | |
| US6555369B2 (en) | Method of stable integration of DNA into neurons | |
| WO2024245132A1 (en) | Optogenetic activation for signal transduction | |
| CN114931652B (zh) | 一种Hmga2基因在修复受损视网膜中的应用 | |
| Verhaagen et al. | Gene Therapy for Spinal Cord Injury | |
| RU2521225C2 (ru) | Способ стимулирования регенерации спинного мозга с помощью генетически модифицированных клеток крови пуповины человека | |
| JPWO2023051802A5 (https=) | ||
| HK40097397A (en) | Functional fragment for reprogramming, composition, and application thereof | |
| CN116970571A (zh) | 一种再生gaba能神经元的方法及其在制备神经病理性疼痛基因治疗药物中的应用 |